InnovHeart
6 known investors
Find your way into InnovHeart
InnovHeart develops the Saturn Transcatheter Mitral Valve Replacement (TMVR) system, a trans-septal mitral valve bioprosthesis used in interventional cardiology to treat mitral valve disease. The company is a medical device maker focused on structural heart interventions for cardiac patients.
Founders & leadership
DJ
David James WilsonChief Executive Officer
Investors · 6
Also in the syndicate · 3
GenextraGrand PharmaleadGrand Pharmaceutical Grouplead
Funding
SEC filings, press & company announcements$55M disclosed across 1 of 2 rounds · 2022–2025
- $55MSeries CJan 2022 · 3 sources
Grand Pharma (lead), Grand Pharmaceutical Group (lead), Genextra, Indaco Venture Partners, Panakes Partners
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 3
by search overlap
Rf Surgical9 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Edwards Lifesciences7 shared keywordsEdwards Lifesciences develops innovative medical technologies for treating cardiovascular disease, focusing on structural heart interventions. The company serves patients and healthcare providers globally through partnerships with clinicians and healthcare stakeholders.
Bioworld6 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with InnovHeart for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does InnovHeart do?
- InnovHeart develops the Saturn Transcatheter Mitral Valve Replacement (TMVR) system, a trans-septal mitral valve bioprosthesis used in interventional cardiology to treat mitral valve disease. The company is a medical device maker focused on structural heart interventions for cardiac patients.
- Who are InnovHeart's investors?
- InnovHeart's investors include CDP Venture Capital, Indaco Venture Partners, Panakes Partners.
- How much funding has InnovHeart raised?
- InnovHeart has disclosed $55M raised across 1 of its 2 known rounds.